ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference
February 05 2008 - 6:00AM
PR Newswire (US)
SAN DIEGO, Feb. 5 /PRNewswire-FirstCall/ -- ADVENTRX
Pharmaceuticals, Inc. (AMEX:ANX), a biopharmaceutical research and
development company focused on commercializing proprietary product
candidates for the treatment of cancer and infectious diseases,
announced today that Evan M. Levine, ADVENTRX's chief executive
officer and president, is scheduled to present at the 10th Annual
BIO CEO & Investor Conference on February 12, 2008 at 10:15
a.m. Eastern Time. The conference takes place in New York at the
Waldorf Astoria hotel, February 11-13, 2008. The presentation will
be webcast live via the "Investors" section of the Company's web
site at http://www.adventrx.com/ under "Events." The webcast will
be available for replay for 14 days and can be accessed through the
same link. About ADVENTRX Pharmaceuticals ADVENTRX Pharmaceuticals
is a biopharmaceutical research and development company focused on
commercializing proprietary product candidates for the treatment of
cancer and infectious diseases. The Company seeks to improve the
performance and safety of existing treatments by addressing
significant problems such as drug metabolism, bioavailability,
excessive toxicity and treatment resistance. More information can
be found on the Company's web site at http://www.adventrx.com/.
DATASOURCE: ADVENTRX Pharmaceuticals, Inc. CONTACT: Investors,
Ioana C. Hone of ADVENTRX Pharmaceuticals, Inc., +1-858-552-0866
Web site: http://www.adventrx.com/
Copyright
Adventrx (AMEX:ANX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adventrx (AMEX:ANX)
Historical Stock Chart
From Jul 2023 to Jul 2024